PL378334A1 - Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie - Google Patents

Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie

Info

Publication number
PL378334A1
PL378334A1 PL378334A PL37833403A PL378334A1 PL 378334 A1 PL378334 A1 PL 378334A1 PL 378334 A PL378334 A PL 378334A PL 37833403 A PL37833403 A PL 37833403A PL 378334 A1 PL378334 A1 PL 378334A1
Authority
PL
Poland
Prior art keywords
culture
medium composition
culture medium
myoblasts obtained
culture method
Prior art date
Application number
PL378334A
Other languages
English (en)
Inventor
Christian Pinset
Original Assignee
Celogos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celogos filed Critical Celogos
Publication of PL378334A1 publication Critical patent/PL378334A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL378334A 2002-12-13 2003-12-12 Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie PL378334A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0215827 2002-12-13

Publications (1)

Publication Number Publication Date
PL378334A1 true PL378334A1 (pl) 2006-03-20

Family

ID=32524649

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378334A PL378334A1 (pl) 2002-12-13 2003-12-12 Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie

Country Status (16)

Country Link
US (1) US20060258003A1 (pl)
EP (1) EP1572988A1 (pl)
JP (1) JP2006509516A (pl)
KR (1) KR20050088118A (pl)
CN (1) CN1723277A (pl)
AU (1) AU2003300585A1 (pl)
BR (1) BR0316757A (pl)
CA (1) CA2509642A1 (pl)
IL (1) IL169115A0 (pl)
MX (1) MXPA05006350A (pl)
NO (1) NO20053357D0 (pl)
NZ (1) NZ540723A (pl)
PL (1) PL378334A1 (pl)
RU (1) RU2005122030A (pl)
WO (1) WO2004055174A1 (pl)
ZA (1) ZA200505125B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100679642B1 (ko) * 2005-11-16 2007-02-06 주식회사 알앤엘바이오 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제
US7611902B2 (en) * 2006-06-12 2009-11-03 Zora Biosciences Oy Diagnostic method for myopathy
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
EP1900810A1 (fr) * 2006-09-15 2008-03-19 Celogos Methode d'extraction et de selection de cellules
US20080208164A1 (en) 2007-02-28 2008-08-28 Innovacell Biotechnologie Gmbh Methods for the treatment of anal incontinence
US20090042296A1 (en) * 2007-03-16 2009-02-12 Marie Callahan Transfection ready eukaryotic cells
RU2459627C2 (ru) * 2007-06-15 2012-08-27 Этикон, Инк. Композиции фрагментов ткани для лечения недержания
CN101386836B (zh) * 2007-09-12 2010-11-24 北京清大天一科技有限公司 动物细胞培养基干粉组合物、培养基组合物及其制备方法
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
EP2397851B1 (fr) 2010-06-21 2015-01-07 Centre d'Etude des Cellules Souches Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines
JP2012029623A (ja) * 2010-07-30 2012-02-16 Bio Link Inc 細胞分離用酵素溶液及び細胞分離方法、並びに膵島分離方法
EP2898089A1 (en) * 2012-09-24 2015-07-29 Innovacell Biotechnologie AG Potency assay for skeletal muscle derived cells
US9982233B2 (en) 2013-12-12 2018-05-29 Samsung Life Public Welfare Foundation Method for promoting generation of stem cell-derived exosome by using thrombin
US10711248B2 (en) 2013-12-18 2020-07-14 Cytoo Device and method for standardizing myoblast differentiation into myotubes
RU2576842C2 (ru) * 2014-02-28 2016-03-10 Общество С Ограниченной Ответственностью "Витацел" Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения
WO2015142061A1 (ko) 2014-03-18 2015-09-24 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
SG11201609980TA (en) 2014-06-18 2016-12-29 Medimmune Llc Cell culture methods and media comprising n-acetylcysteine
KR101960497B1 (ko) * 2016-05-09 2019-03-21 고려대학교 산학협력단 소변 유래 세포 배양용 배지 조성물
WO2019016795A1 (en) * 2017-07-15 2019-01-24 Technion Research & Development Foundation Limited CURVED CARNEY COMPOSITIONS
BR112021015887A8 (pt) * 2019-02-13 2023-04-11 Tigenix S A U Método para criopreservação de célula-tronco, população de células-tronco, composição de criopreservação, uso de nac, e kit de criopreservação
CN112592890A (zh) * 2020-12-17 2021-04-02 江南大学 一种促进肌肉干细胞增殖的方法
US20240182859A1 (en) * 2021-03-29 2024-06-06 Hyupsung University Industry-Academic Cooperation Foundation Medium composition for culturing muscle stem cell comprising curcumin longa, glysin, or insulin for proliferation of muscle stem cell
CN114752590B (zh) * 2022-01-14 2023-09-08 江南大学 一种高效且经济的猪肌肉干细胞的分离方法及其应用
CN117625519B (zh) * 2022-08-12 2025-03-25 江南大学 促肌肉干细胞体外存活和增殖的无胎牛血清培养基及其应用
CN117925509B (zh) * 2024-03-25 2024-06-11 山东三链医疗科技有限公司 一种细胞培养替代血清培养液及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium

Also Published As

Publication number Publication date
JP2006509516A (ja) 2006-03-23
ZA200505125B (en) 2006-03-29
MXPA05006350A (es) 2006-02-08
KR20050088118A (ko) 2005-09-01
WO2004055174A1 (fr) 2004-07-01
CA2509642A1 (fr) 2004-07-01
RU2005122030A (ru) 2005-12-20
BR0316757A (pt) 2005-10-25
NO20053357L (no) 2005-07-11
AU2003300585A1 (en) 2004-07-09
CN1723277A (zh) 2006-01-18
NZ540723A (en) 2008-04-30
IL169115A0 (en) 2007-07-04
US20060258003A1 (en) 2006-11-16
EP1572988A1 (fr) 2005-09-14
NO20053357D0 (no) 2005-07-11

Similar Documents

Publication Publication Date Title
IL169115A0 (en) Culture medium composition culture method, and myoblasts obtained, and their uses
AU2002337497A1 (en) Carbon material, production method and use thereof
AU2003274906A1 (en) Double stranded rna structures and constructs, and methods for generating and using the same
MX256798B (es) Dispersiones de polimeros en medio organico y composiciones que las comprenden.
AU2002234076A1 (en) Construction composition, structure, and method
GB0219825D0 (en) Process for producing and recovering mannosylerythritol lipidsfrom culture medium containing the same
AU2001280149A1 (en) Stem cell culture medium and culture method by using the same
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2003236118A1 (en) An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor
AU2003265040A1 (en) Drill rod and method in order to manufacture the same
AU2003247449A1 (en) Nano-ceramics and method thereof
AU2003289651A1 (en) Pcr method and application by transnormal low thermo-denaturation temperature
AU2003237332A1 (en) Anti-relp fusion antibodies, compositions, methods and uses
AU2003250545A1 (en) Recording apparatus, recording method and recording medium
AU2001234616A1 (en) Vaccine composition, process and methods
IL159856A0 (en) Fermentation medium and method
AU4771600A (en) Cells, culture methods and their uses
AU2001277742A1 (en) Solid culture medium and method for preparing the same
AU2003292754A1 (en) Composition for forming silicon7aluminum film, silicon7aluminum film and method for forming the same
AU2003266402A1 (en) Medium containing water with increased viscosity, method for production and use thereof
AU2003292099A1 (en) Iron-nickel-cobalt alloy, method for the production and use thereof
AU2003267993A8 (en) Monooxygenases, nucleic acids encoding them and methods for making and using them
GB0305089D0 (en) Composition, use and process
AU2003264894A1 (en) Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses
AU2002314215A1 (en) Enzymatic method of producing 4-0-beta-D galactopyranosyl-D-xylose, 4-0-beta-D-galactopyranosyl-D-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)